Serum vitamin E levels in patients of chronic myeloid leukaemia.
Artículo
en Inglés
| IMSEAR
| ID: sea-86253
ABSTRACT
OBJECTIVE:
To estimate vitamin E levels in sera of patients of chronic myeloid leukaemia (CML) before and after treatment with busulphan and hydroxyurea and to compare the levels with those in healthy controls.METHODS:
The study was carried out in a total of 50 subjects (mean age 34 +/- 8.86 years; 25 were proved cases of CML and 25 were healthy controls. Vitamin E level was measured by spectrofluorometeric method. In patients of CML vitamin E level was estimated twice i.e. once when their total leucocyte count (TLC) was raised (i.e. before treatment) and then after treatment after bringing the TLC near normal.RESULTS:
The mean serum vitamin E level in 25 normal healthy controls was 7.19 micrograms/ml and that in 25 patients of CML at presentation (before treatment) was 2.67 micrograms/ml. It increased to 3.61 micrograms/ml after treatment.CONCLUSION:
The results show that patients of CML have a significantly lower (p < 0.001) level of serum vitamin E as compared to normal healthy adults and that the level of vitamin E increased significantly (p < 0.001) after treatment even without supplementing vitamin E.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Espectrometría de Fluorescencia
/
Vitamina E
/
Busulfano
/
Humanos
/
Leucemia Mielógena Crónica BCR-ABL Positiva
/
Estudios de Casos y Controles
/
Antineoplásicos Alquilantes
/
Adulto
/
Hidroxiurea
/
Antineoplásicos
Tipo de estudio:
Estudio observacional
Idioma:
Inglés
Año:
1999
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS